I’m thinking this might represent formal authorization...

I’m thinking this might represent formal authorization (formulary inclusion) of Daybue for those covered by VA healthcare, which includes families of military service veterans. Authorization is for a bottle a month per patient, as is seen in other formulary inclusions for Daybue.

In that case, it would suggest budgeting for approximately 175 Rett patients who are children of ex-service men and women?

The dates are confusing, but I think that the contract date of 29/12/16 might refer to VA’s first acquisition contract with Acadia, for Nuplazid, which was approved by the FDA earlier in 2016.

But this is just my thinking…